Compounds > cilostazol

cilostazol and nafronyl

cilostazol has been researched along with nafronyl in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (50.00)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Hiatt, WR1
Doggrell, SA1
Conners, MS; Money, SR1
Landi, A1
Clegg, JP; Davie, AM; Guest, JF1
Dobesh, PP; Persson, EL; Stacy, ZA1
Harnan, S; Meng, Y; Michaels, J; Simpson, E; Squires, H; Stansby, G; Stevens, J; Thomas, S; Wong, R1
Harnan, S; Meng, Y; Michaels, J; Simpson, E; Squires, H; Stansby, G; Stevens, JW; Thomas, S1
Harnan, S; Meng, Y; Michaels, J; O'Donnell, ME; Simpson, E; Squires, H; Stansby, G; Stevens, JW; Thomas, S1
Melzer, J; Saller, R1
Hong, H; Mackey, WC1
Arıkan, AA; Eraldemir, FC; Gülaştı, ÖF; Kır, HM; Özbudak, E; Şahin, D; Yavuz, Ş1

Reviews

9 review(s) available for cilostazol and nafronyl

ArticleYear
New treatment options in intermittent claudication: the US experience.
    International journal of clinical practice. Supplement, 2001, Issue:119

    Topics: Arginine; Carnitine; Cilostazol; Endothelial Growth Factors; Exercise Therapy; Humans; Intermittent Claudication; Multicenter Studies as Topic; Nafronyl; Pentoxifylline; Phosphodiesterase Inhibitors; Prostaglandins; Quality of Life; Randomized Controlled Trials as Topic; Serotonin Antagonists; Tetrazoles; United States

2001
Pharmacotherapy of intermittent claudication.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:11

    Topics: Animals; Anticoagulants; Cardiotonic Agents; Carnitine; Cilostazol; Humans; Intermittent Claudication; Nafronyl; Nitric Oxide; Pentoxifylline; Platelet Aggregation Inhibitors; Tetrazoles; Vasodilator Agents

2001
Can claudication be improved with medication?
    Seminars in vascular surgery, 2002, Volume: 15, Issue:4

    Topics: Carnitine; Cilostazol; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Prostaglandins; Tetrazoles; Ticlopidine; Vasodilator Agents

2002
[Secondary prevention and conservative therapy of obliterative arteriosclerosis].
    Orvosi hetilap, 2004, May-16, Volume: 145, Issue:20

    Topics: Arteriosclerosis Obliterans; Cilostazol; Clinical Trials as Topic; Epoprostenol; Exercise; Hematologic Agents; Hemodilution; Hemorheology; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Intermittent Claudication; Nafronyl; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrrolidines; Risk Factors; Smoking; Tetrazoles; Vasodilator Agents; Walking

2004
Pharmacologic therapy for intermittent claudication.
    Pharmacotherapy, 2009, Volume: 29, Issue:5

    Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy; Guidelines as Topic; Humans; Intermittent Claudication; Meta-Analysis as Topic; Nafronyl; Pentoxifylline; Peripheral Vascular Diseases; Pyrrolidines; Risk Factors; Tetrazoles; Treatment Outcome

2009
A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.
    Health technology assessment (Winchester, England), 2011, Volume: 15, Issue:40

    Topics: Cilostazol; Cost-Benefit Analysis; Humans; Intermittent Claudication; Nafronyl; Nicotinic Acids; Pentoxifylline; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Tetrazoles; United Kingdom; Vasodilator Agents

2011
Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    The British journal of surgery, 2012, Volume: 99, Issue:12

    Topics: Cilostazol; Humans; Intermittent Claudication; Nafronyl; Pain; Pentoxifylline; Peripheral Vascular Diseases; Randomized Controlled Trials as Topic; Tetrazoles; Treatment Outcome; Vasodilator Agents; Walking

2012
[Clinical studies in peripheral arterial occlusive disease: update from the aspects of a meta-narrative review].
    Forschende Komplementarmedizin (2006), 2013, Volume: 20 Suppl 2

    Topics: Arterial Occlusive Diseases; Cilostazol; Complementary Therapies; Humans; Intermittent Claudication; Medicine, Tibetan Traditional; Nafronyl; Pentoxifylline; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Tetrazoles; Triglycerides; Walking

2013
The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Clinical therapeutics, 2014, Aug-01, Volume: 36, Issue:8

    Topics: Cilostazol; Clinical Trials as Topic; Drug Approval; Endpoint Determination; Humans; Intermittent Claudication; Nafronyl; Research Design; Tetrazoles; United Kingdom; United States; Vasodilator Agents

2014

Other Studies

3 other study(ies) available for cilostazol and nafronyl

ArticleYear
Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Current medical research and opinion, 2005, Volume: 21, Issue:6

    Topics: Adult; Cilostazol; Cost-Benefit Analysis; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; State Medicine; Tetrazoles; United Kingdom; Vasodilator Agents; Walking

2005
Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Angiology, 2014, Volume: 65, Issue:3

    Topics: Cilostazol; Cost-Benefit Analysis; Decision Support Techniques; Humans; Intermittent Claudication; Markov Chains; Nafronyl; Pentoxifylline; Peripheral Arterial Disease; Tetrazoles; Vasodilator Agents

2014
Comparison of Cilostazol and Naftidrofuryl in an Experimental Acute Ischemia-Reperfusion Model.
    Vascular and endovascular surgery, 2021, Volume: 55, Issue:1

    Topics: Animals; Antioxidants; Biomarkers; Brain; Cilostazol; Disease Models, Animal; Kidney; Liver; Male; Muscle, Skeletal; Myocardial Reperfusion Injury; Nafronyl; Oxidative Stress; Rats, Wistar; Reperfusion Injury

2021